Admission to drug treatment and rehabilitation centers to resume with strict health and safety protocols amid the pandemic

Adjusting to the “New Normal,” the Dangerous Drugs Board (DDB) adopted infection prevention and control protocol to be followed upon the resumption of admissions and activities in drug treatment and rehabilitation facilities nationwide.

Read more ...

DDB issues policy to ensure availability of physicians authorized to assess substance use disorder amid the pandemic

The Dangerous Drugs Board, in its recent special meeting, approved a Resolution extending the validity of provisional accreditation granted to physicians authorized to conduct Drug Dependency Examination (DDE) for a period of two years.

Read more ...

DDB refutes heavy-handed approach in UN-OHCHR drug war report

The Philippine Government takes exception to the Office of the United Nations High Commissioner for Human Rights (OHCHR) Report, especially as it relates to Philippine efforts to effectively address the pervasive menace and destructive effects of illegal drugs in the country.

The Philippines calls on the OHCHR to foster a positive spirit of cooperation with States Parties, with the view of releasing an unbiased report based on facts, legitimate figures and continuing consultations with key anti-drug agencies in the Philippines.

Read more ...

Statement of the DDB on the change of leadership in the Philippine Drug Enforcement Agency

The Dangerous Drugs Board welcomes the assumption of new PDEA Director General Wilkins Villanueva after Malacañang released his appointment signed last 22 May 2020. Incoming DG Villanueva has been a steadfast partner of DDB even during his early years as career officer of PDEA. DDB has involved him in many of its anti-drug efforts particularly in policy formulation and strategy development aspects which helped craft many of its inter-agency priorities all these years. Recognizing him as the 7th Director-General of PDEA, DDB intends to engage more closely and deepen the collaboration with his leadership noting that he will become an Ex-Officio Member of the Board.

Read more ...

DDB Eases the Use of Prescription Forms for Dangerous Drugs

The Dangerous Drugs Board now allows the use of ordinary prescription for medical preparations containing dangerous drugs.

Read more ...

DDB advocates for the use of electronic prescription for dangerous drugs medication

The Dangerous Drugs Board appeals to doctors, pharmacists, and drug store personnel to consider the use of electronic prescription for medicines included in the list of dangerous drugs as the whole country is under a State of Calamity due to the COVID-19 pandemic.

Read more ...

DDB, SDA Church hold program to update health directors on the Philippine Anti-Illegal Drugs Strategy (PADS) and board regulations

The Dangerous Drugs Board, in collaboration with the Southern Asia-Pacific Division of the Seventh-Day Adventist Church, convenes Luzon-based health directors of the religious group to update them on the Philippine Anti-Illegal Drugs Strategy (PADS) and relevant DDB regulations.

Read more ...

DDB clarifies: CBD is not cannabis per se

The Dangerous Drugs Board would like to clarify that marijuana use remains illegal in the country for both recreational and medical use. The use of Cannabidiol, however, is being considered to be allowed for treatment of certain rare forms of epilepsy like Lennox-Gastaut and Dravet Syndrome.

Read more ...

DDB, DOST-FNRI launch dietary manuals for Persons Who Use Drugs (PWUDs)

The Dangerous Drugs Board and the Department of Science and Technology-Food and Nutrition Research Institute, officially launch three dietary manuals to be used in Treatment and Rehabilitation Centers (TRCs) in the Philippines.

Read more ...

(Facility Based)
CY 2002

AGE : Mean age of 27 years
SEX : Ratio of male to female 11:1
CIVIL STATUS : Single 52.95%
                         Married 33.51%
FAMILY SIZE : Two (2) to three (3) siblings
STATUS OF EMPLOYMENT : Private Employee 30.17%
                                              Government Employee 1.26%
                                              Unemployed 31.76%
                                              Self – Employed 12.65%
                                              Students 6.38%
                                              Out of school youth 0.69%
ECONOMIC STATUS : Average Monthly Family Income Php11,114.29
PLACE OF RESIDENCE : Urban (specifically Metro Manila)
DURATION OF DRUG - TAKING : More than two (2) years
I.Q. : Average
NATURE OF DRUG – TAKING : Mono – drug use


       For the year 2002, majority of center admissions were males with 91.74%. The ratio of male to female is 11:1. Single clients comprised 52.95%, while married ones represented 33.5%. Significantly, of the total number of admissions, 7.20% had live-in partners while 5.30% were separated from their spouses.

       Percent distribution as to educational attainment showed that most of the centers clients were in the high literacy level. Of the total number, 29.23% were in high school, 14.01% were high school graduates, 30.96% in the college level while 9.10% were already college graduates prior to their admission in the centers.

       The age groups of 20-24 and 25-29 occupy the highest percent distributions of center clients admitted in 2002, with 22.64% and 19.56%, respectively. The mean or the average age remains to be 27 years old.

       As to the occupational status, 32.65% of the total number of reported cases belonged to the workers group, 12.65% self-employed, students, 6.38% and out-of-school youths, 0.69%.

       The average monthly income of center clients rose to P11, 114.29 as compared to P7, 800.81 in 2001. Increase in the average monthly income was more likely brought by the income of those clients who belonged to the rich families in the private centers.


       A total of 5,965 admission cases were reported by various residential and out-patient centers nationwide in 2002. Of this number 4,565 were reported by various residential facilities, of which 1,062 are readmission while 338 came from our-patient centers. 

(Facility based)
CY 2002

TYPE OF ADMISSION                                       

  No. %
New Admissionl 4,903 82.20
Re-Admissions 1,062 17.80
Total 5,965 100.00


Analysis of Data

       To date, there were 45 residential and 4 out-patient centers nationwide reporting actively to the Secretariat.

       As of CY 2002, a total of 5,965 admissions were reported by these centers. Of this number, 4,565 were newly admitted from residential centers, 1,062 were relapsed cases, and 338 were reporting in out-patient centers. Compared to the previous year (2001), there was a decrease rate of 17.53% in new admissions and an increase rate of 6.09% in relapse cases. The decrease in the number of new admissions were more likely the result of overcrowding in government centers, high cost of treatment, and rehabilitation in most private centers and the passage of the stricter Comprehensive Dangerous Drugs Act of 2002. The increase in the number of relapse cases may be attributed to some clients who were not yet motivated to change or accept the reality that they need professional help. It may also be due to peer pressure, which they found difficult to resist after discharge from the rehabilitation centers.

       The highest percent distribution of cases came from the National Capital Region or Metro Manila area with 2,497 or 51% of the total admissions nationwide. It was followed by Region III (20.58%) and Region IV (16.42%). 

CY 2002

1. Methamphetamine Hydrochloride (Shabu) 3,349 68.31
2. Cannabis (Marijuana) 1,366 27.86
3. Inhalants (Rugby) 82 1.67
4. Corex –DM (Cough/Cold Preparation) 72 1.47
5. Hashish (Cannabis) 57 1.16
6. Cocaine (Stimulant) 52 1.06
7. Brownies/Cake (Cannabis) 50 1.02
8. Ecstacy (Stimulant) 38 0.78
9. Trazepam ( Benzodiazepine 36 0.73
Nubain (Narcotic/Analgesic) 36 0.73

       Methamphetamine Hydrochloride or Shabu remains the No. 1 drug of abuse with 3,349 cases or 68.31%. It was followed by Marijuana, 1,366 (27.86%), Rugby or Inhalant, 82 cases (1.67%). Significantly, Ecstasy, the emerging drug of abuse in the country, was reported as No. 8 with 38 cases or 0.78%. Route of administration was reported to be that of inhalation, sniffing or taken orally.